CLASS II ONGOING Device recall · Reported 1 Jan 2025 · FDA Enforcement Report

Access hsTnI Reagent recalled by Beckman Coulter

Beckman Coulter is recalling Access hsTnI Reagent. The recall was initiated on 18 Nov 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI/DI 15099590693183, All Lots
Quantity recalled2,109,804 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0727-2025
FDA event ID
95816
Recalling firm
Beckman Coulter, Chaska, MN
Classification
Class II
Status
Ongoing
Recall initiated
18 Nov 2024
FDA classified
20 Dec 2024
Reported
1 Jan 2025
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Potency & Assay

Timeline

18 Nov 2024Recall initiated by company
20 Dec 2024Classified by FDA+32 days
1 Jan 2025Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Beckman Coulter, Inc. is recalling their Access hsTnI assay, a medical device by correction. The reason for the recall is: high troponin antigen (>55,000 pg/mL) can contaminate an analyzers probe and cause inter-assay carryover due to insufficient washing. The contamination can cause a falsely elevated Access hsTnI result in subsequent sample(s) which can impact patient care (potentially but not limited to unnecessary coronary imaging or diagnostic catheterization) if the result is near the medical decision points.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Access hsTnI Reagent, REF B52699, Immunoassay Method, Troponin Subunit. For the quantitative determination of cardiac troponin I (cTnI) levels in human serum and plasma.

Where it was distributed

Worldwide

Questions about this recall

Is Access hsTnI Reagent recalled?

Yes. Beckman Coulter recalled Access hsTnI Reagent on 18 Nov 2024. The recall is Class II and its status is Ongoing. Recall number Z-0727-2025.

Why was it recalled?

Beckman Coulter, Inc. is recalling their Access hsTnI assay, a medical device by correction. The reason for the recall is: high troponin antigen (>55,000 pg/mL) can contaminate an analyzers probe and cause inter-assay carryover due to insufficient washing. The contamination can cause a falsely elevated Access hsTnI result in subsequent sample(s) which can impact patient care (potentially but not limited to unnecessary coronary imaging or diagnostic catheterization) if the result is near the medical decision points.

Which lots are affected?

UDI/DI 15099590693183, All Lots

Where was it sold?

Worldwide

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Beckman Coulter

All 334

Other Test Kits & Diagnostics recalls

All 2,656